Age-Related Low Bone Mineral Density in C57BL/6 Mice Is Reflective of Aberrant Bone Morphogenetic Protein-2 Signaling Observed in Human Patients Diagnosed with Osteoporosis.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
23 Sep 2022
Historique:
received: 14 08 2022
revised: 11 09 2022
accepted: 21 09 2022
entrez: 14 10 2022
pubmed: 15 10 2022
medline: 18 10 2022
Statut: epublish

Résumé

Osteoporosis (OP) is a bone disorder characterized by decreased bone mineral density (BMD). Bone Morphogenetic Protein-2 (BMP-2) injections are used to promote bone formation in OP patients. However, patients are unresponsive to BMP-2 while displaying an upregulation of BMP Receptor Type 1a (BMPRIa) and protein kinase CK2α (CK2α). A synthetically produced peptide named casein kinase 2.3 (CK2.3) utilizes the BMP-signaling pathway as it enhances osteogenesis of primary osteoblasts isolated from OP patients, whereas BMP-2 does not. Although shown in OP patients, there is currently no reliable mouse model to study BMP-2 and CK2.3 signaling. In this publication, we show that BMPRIa was required for CK2.3-mediated osteogenesis in C2C12 cells with a CRISPR-Cas9-mediated gene knockout for

Identifiants

pubmed: 36232525
pii: ijms231911205
doi: 10.3390/ijms231911205
pmc: PMC9570292
pii:
doi:

Substances chimiques

Bone Morphogenetic Protein 2 0
Casein Kinase II EC 2.7.11.1
Bone Morphogenetic Protein Receptors EC 2.7.11.30

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Nathan Shock Center
ID : Pilot Award
Organisme : NIAMS NIH HHS
ID : 1R21AR076689-01A1
Pays : United States
Organisme : National Institute of Health's General Medical Sciences
ID : P20GM103446
Organisme : National Institute of Health's General Medical Sciences
ID : P20GM139760
Organisme : NIGMS NIH HHS
ID : P20 GM139760
Pays : United States

Références

Mol Cell Biol. 2017 Feb 1;37(4):
pubmed: 27920253
Int J Mol Sci. 2020 Jul 10;21(14):
pubmed: 32664215
Nanomaterials (Basel). 2018 Jul 09;8(7):
pubmed: 29987256
Circ Res. 2005 Aug 5;97(3):219-26
pubmed: 16037571
Br Med J. 1980 Jun 7;280(6228):1340-4
pubmed: 6992932
J Cell Biochem. 2010 Mar 1;109(4):672-82
pubmed: 20039313
J Bone Miner Res. 2014 Nov;29(11):2520-6
pubmed: 24771492
Acta Biochim Biophys Sin (Shanghai). 2018 Jan 1;50(1):12-36
pubmed: 29293886
Biophys J. 2009 Sep 2;97(5):1428-35
pubmed: 19720031
J Dev Biol. 2020 Jul 09;8(3):
pubmed: 32660129
Mol Biol Cell. 2000 Mar;11(3):1023-35
pubmed: 10712517
Drug Discov Today. 2014 Mar;19(3):204-8
pubmed: 23932952
J Orthop Res. 2017 Apr;35(4):876-885
pubmed: 27312334
Biochem Biophys Res Commun. 2014 Jan 24;443(4):1136-40
pubmed: 24361959
Bone Res. 2016 Apr 26;4:16009
pubmed: 27563484
Bone. 2011 Nov;49(5):944-54
pubmed: 21763800
J Bone Res. 2018;6(2):
pubmed: 30294717
Biophys J. 2010 Aug 4;99(3):897-904
pubmed: 20682268
J Cell Commun Signal. 2013 Dec;7(4):265-78
pubmed: 23637019
Osteoporos Int. 2007 Jan;18(1):59-68
pubmed: 17013567
Ann Pharmacother. 2012 Mar;46(3):419-23
pubmed: 22333262
Spine J. 2014 Mar 1;14(3):552-9
pubmed: 24412416
J Cell Physiol. 2012 Jul;227(7):2870-9
pubmed: 22170575
Birth Defects Res A Clin Mol Teratol. 2011 Jun;91(6):441-8
pubmed: 21384533
Int J Spine Surg. 2018 Aug 15;12(3):322-327
pubmed: 30276088
J Bone Miner Res. 2007 Oct;22(10):1479-91
pubmed: 17663640
Front Endocrinol (Lausanne). 2017 May 01;8:96
pubmed: 28507534
Bone. 2012 Jan;50(1):189-99
pubmed: 22036911
JBMR Plus. 2019 Aug 02;3(10):e10211
pubmed: 31687647
Front Cell Neurosci. 2013 Jun 04;7:87
pubmed: 23761735
J Cell Sci. 2005 Feb 1;118(Pt 3):643-50
pubmed: 15657086
Global Spine J. 2017 Apr;7(2):148-153
pubmed: 28507884
PLoS One. 2016 Oct 4;11(10):e0163530
pubmed: 27701417
Med J Islam Repub Iran. 2020 Nov 12;34:154
pubmed: 33437750
Int J Mol Sci. 2019 May 21;20(10):
pubmed: 31117181
Cell Signal. 2004 Mar;16(3):291-9
pubmed: 14687659
Int J Biol Sci. 2012;8(2):272-88
pubmed: 22298955
Spine J. 2012 Oct;12(10):881-90
pubmed: 23098617
J Dev Biol. 2020 Sep 13;8(3):
pubmed: 32933207
J Bone Miner Res. 2018 Aug;33(8):1407-1416
pubmed: 29750828
Int J Mol Sci. 2019 Nov 23;20(23):
pubmed: 31771161
J Dev Biol. 2021 Jun 28;9(3):
pubmed: 34203252
J Cell Physiol. 2012 Jul;227(7):2880-8
pubmed: 21938723
Int J Mol Sci. 2020 Sep 21;21(18):
pubmed: 32967078
Nanomaterials (Basel). 2020 Jun 20;10(6):
pubmed: 32575709
J Bone Miner Res. 2003 Oct;18(10):1842-53
pubmed: 14584895
Lancet. 2017 Sep 30;390(10102):1585-1594
pubmed: 28755782
JAMA. 2010 Aug 11;304(6):657-63
pubmed: 20699457
Sci Rep. 2016 Jun 22;6:28537
pubmed: 27329730
Drug Healthc Patient Saf. 2011;3:79-91
pubmed: 22279412
Chronic Dis Transl Med. 2015 Mar 21;1(1):9-13
pubmed: 29062981
J Biol Chem. 1996 Jul 26;271(30):18188-93
pubmed: 8663410
Tissue Eng Part B Rev. 2016 Aug;22(4):284-97
pubmed: 26857241
Wien Med Wochenschr. 2020 Apr;170(5-6):124-131
pubmed: 31858345
PLoS One. 2012;7(8):e41460
pubmed: 22916109
J Orthop Res. 2015 Feb;33(2):208-15
pubmed: 25331517
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12670-5
pubmed: 19620713
J Cell Sci. 2003 Aug 15;116(Pt 16):3277-84
pubmed: 12829744
Ther Adv Musculoskelet Dis. 2018 Jun;10(5-6):105-115
pubmed: 29942362
Spine J. 2011 Jun;11(6):471-91
pubmed: 21729796
Case Rep Endocrinol. 2014;2014:802473
pubmed: 25202461
Int J Mol Sci. 2019 May 06;20(9):
pubmed: 31064048
Chin J Traumatol. 2017 Feb;20(1):1-3
pubmed: 28236566
Cells Tissues Organs. 2009;189(1-4):275-83
pubmed: 18765930
J Dev Biol. 2022 Jul 27;10(3):
pubmed: 35997395
J Dev Biol. 2022 Jan 18;10(1):
pubmed: 35225960
J Popul Ther Clin Pharmacol. 2020 Jan 06;27(1):e25-e31
pubmed: 31922699
Spine J. 2011 Jun;11(6):522-6
pubmed: 20598649

Auteurs

Daniel Halloran (D)

Department of Biological Sciences, University of Delaware, Newark, DE 19716, USA.

Venu Pandit (V)

Department of Biological Sciences, University of Delaware, Newark, DE 19716, USA.

Connor MacMurray (C)

Department of Biological Sciences, University of Delaware, Newark, DE 19716, USA.

Victoria Stone (V)

Department of Biological Sciences, University of Delaware, Newark, DE 19716, USA.

Kailey DeGeorge (K)

Department of Biological Sciences, University of Delaware, Newark, DE 19716, USA.

Mark Eskander (M)

Delaware Orthopaedic Specialists, Newark, DE 19713, USA.

Denise Root (D)

Orthopedic Surgery, ChristianaCare Hospital, Wilmington, DE 19801, USA.

Sean McTague (S)

Department of Biological Sciences, University of Delaware, Newark, DE 19716, USA.
Orthopedic Surgery, ChristianaCare Hospital, Newark, DE 19716, USA.

Heather Pelkey (H)

Orthopedic Surgery, ChristianaCare Hospital, Newark, DE 19716, USA.

Anja Nohe (A)

Department of Biological Sciences, University of Delaware, Newark, DE 19716, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH